Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine. (Q54245802)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine. |
scientific article |
Statements
Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine. (English)
U Jehn
V Heinemann
1 March 1993
66
3
131-134
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference